drugset / Trial / NCT03889145

A Study to Evaluate the Drug-drug Interaction Between Telmisartan, Amlodipine and Hydrochlorothiazide

NCT03889145

Phase 1 Completed 30 enrolled IlDong Pharmaceutical Co Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, single dose, 3-way crossover study to evaluate the drug-drugs interaction between Telmisartan, Amlodipine and Hydrochlorothiazide in healthy male volunteers

Timeline

Start
2013-12-19
Primary completion
2014-02-19
Completion
2014-02-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral
Subject Telmisartan Other / unclassified 80 mg Oral

Indications

No indication recorded.